MDisrupt + MedTech Impact Partners | A Partnership to Provide More Regulatory Support to Digital Health Companies
Medtech Impact Partners is partnering with MDisrupt to meet the growing need for regulatory support and strategy. There is a constant evolution of regulations with increasing significance in the field of health technology. Having access to experts with specialized knowledge and experience in regulatory affairs can significantly streamline the process of gaining necessary approvals and certifications. It enables companies to ensure compliance with regulatory requirements, expedite product development timelines, and ultimately bring innovative health technologies to market more efficiently, benefiting patients and healthcare providers alike.
Kwame Ulmer, Managing Partner of MedTech Impact Partners
“Medtech companies have done the hard work of creating life-changing innovations. Our team at Medtech Impact Partners leverages decades of insights and expertise to remove hurdles that will slow their path to market. We focus our work in regulatory strategy to keep pace with evolving needs. We make it our mission to be an effective regulatory partner for digital health companies and our partnership with MDisrupt enables us to offer more support globally,” said Kwame Ulmer, Managing Partner of Medtech Impact Partners.
MDisrupt, the healthtech industry’s leading marketplace for health experts on demand, is actively creating new opportunities for their health technology clients to access a wider range of best in class experts related to regulatory strategy and submissions.
“Establishing a robust regulatory process is arguably one of the most critical steps in successfully building a product that scales into the healthcare system.” said Ruby Gadelrab, CEO of MDisrupt. “Due to the ever-changing regulatory landscape and the number of companies building products that need to be implemented by health systems and reimbursed by payors, we are seeing increasing demand for regulatory expertise. We are so proud to be partnering with MedTech Impact Partners to expand our services.”
Ruby Gadelbrab, CEO of MDisrupt
Through this collaboration, MedTech Impact Partners and MDisrupt are providing streamlined access to industry leading regulatory experts on demand, providing crucial support for minimizing risks, avoiding delays, and ultimately bringing innovative healthcare solutions to patients efficiently and safely.
In addition, MDisrupt's expert network extends to more than 1,200 professionals encompassing clinicians, payors, health economists, scientists, as well as product and commercialization experts. This vast network can be leveraged to provide comprehensive support to both our existing and prospective clients at Medtech Impact Partners.
About Medtech Impact Partners “Talk to the FDA before you talk to the FDA.”
MedTech Impact Partners is a leader in regulatory strategy and support. Built on decades of government and private sector experience, our services position clients to get innovative health technologies to market faster.
Our team of consultants guide MedTech companies over regulatory hurdles at the FDA, helping them deliver on key milestones and protect their bottom line. MIP’s customized approach and suite of services focus on developing sound regulatory strategy, diligent review, and managing risks for clients.
MDisrupt is the health technology industry’s leading expert marketplace, connecting innovators with vetted and curated health expert operators to help them build, commercialize and scale their products quickly and responsibly.
With its tech-enabled platform, MDisrupt simplifies and democratizes access to the most experienced experts in healthcare, including clinicians, regulatory experts, payors, health economists, and product and commercialization leaders.
Earning the trust of a growing network of startups, investors, and healthcare companies, MDisrupt has solidified its position as the industry’s go-to talent marketplace for fractional health expertise.